June 12, 2020 / 8:48 PM / a month ago

BRIEF-Principia Announces Positive Data From Its Phase 2 Part B Trial In Pemphigus

June 12 (Reuters) - Principia Biopharma Inc:

* PRINCIPIA ANNOUNCES POSITIVE DATA FROM ITS PHASE 2 PART B TRIAL IN PEMPHIGUS

* PRINCIPIA BIOPHARMA INC - CLEAR DOSE-RESPONSE COMBINED WITH DECREASED DAILY CORTICOSTEROID USAGE

* PRINCIPIA BIOPHARMA INC - RESPONSE RATE INCREASED WITH EXTENDED DURATION OF TREATMENT TO SIX MONTHS WHILE MAINTAINING A FAVORABLE SAFETY PROFILE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below